LGVN
Longeveron LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.73M
P/E Ratio
—
EPS
$-1.14
Beta
-0.38
52W High
$1.80
52W Low
$0.47
50-Day MA
$0.88
200-Day MA
$0.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Longeveron LLC
Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions. The company is headquartered in Miami, Florida.
Fundamentals
| Revenue (TTM) | $1.22M |
| Gross Profit (TTM) | 792,000 |
| EBITDA | $-21.62M |
| Operating Margin | -1149.00% |
| Return on Equity | -135.20% |
| Return on Assets | -67.40% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $0.52 |
| Price-to-Book | 1.55 |
| Price-to-Sales (TTM) | 20.34 |
| EV/Revenue | 8.09 |
| EV/EBITDA | -49.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.50% |
| Shares Outstanding | $30.15M |
| Float | $25.33M |
| % Insiders | 9.72% |
| % Institutions | 14.09% |
Historical Volatility
HV 10-Day
60.46%
HV 20-Day
71.11%
HV 30-Day
70.64%
HV 60-Day
78.24%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($7.15 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026